* Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) Clearance * Introduces 'Neuro...
* New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensi...
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology a...
* Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET * Imp...
- Invited Neurophet's scientific advisor Stephen Salloway, professor of Neurology at Brown Medical ...
- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global ...
- Neurophet accelerates global expansion for research and partnership in AI-driven brain image anal...
- Demonstrates Neurophet AQUA AD for AD treatments such as Leqembi and Kisunla - Introduces updated...
- Presents a poster identifying tDCS effects for patients with AD and cognitively normal people - ...
* Neurophet's AI brain image analysis technology improves time and cost efficiency for drug devel...
- Showcases brain imaging analysis technology with key products Neurophet AQUA and Neurophet SCALE ...
- Introducing Alzheimer's disease related brain image analysis technology including Neurophet AQUA ...
- Aim to evaluate and explore the commercialization opportunities of an amyloid-positive prediction...
- New brain image analysis solution for Alzheimer's disease treatment is planned to be commerciali...
- Flagship products Neurophet AQUA and Neurophet SCALE PET both received 510k - Plans to cooperate ...
* Introducing brain imaging analysis solutions including Neurophet AQUA and Neurophet SCALE PET ...
̵ Introducing 4 products at the booth including the main product Neurophet AQUA ̵ Conducting in-dep...
